| pubmed-article:19756557 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19756557 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19756557 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:19756557 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:19756557 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:19756557 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:19756557 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:19756557 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19756557 | pubmed:dateCreated | 2010-1-21 | lld:pubmed |
| pubmed-article:19756557 | pubmed:abstractText | Infliximab, a monoclonal antibody, is approved for the treatment of inflammatory diseases at doses that depend on the patient disease population. It was the aim of this study to evaluate its population pharmacokinetics in patients with moderately to severely active ulcerative colitis and characterize patient covariates that affect its disposition in this population. | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19756557 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19756557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19756557 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19756557 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19756557 | pubmed:issn | 1432-1041 | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:DavisHugh MHM | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:FasanmadeAded... | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:ZhouHonghuiH | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:HuChuanpuC | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:FordJoyceJ | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:JohannsJewelJ | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:AdedokunOmoni... | lld:pubmed |
| pubmed-article:19756557 | pubmed:author | pubmed-author:HernandezDani... | lld:pubmed |
| pubmed-article:19756557 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19756557 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:19756557 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19756557 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19756557 | pubmed:pagination | 1211-28 | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:meshHeading | pubmed-meshheading:19756557... | lld:pubmed |
| pubmed-article:19756557 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19756557 | pubmed:articleTitle | Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis. | lld:pubmed |
| pubmed-article:19756557 | pubmed:affiliation | Centocor Research and Development, Inc, Malvern, PA, USA. afasanma@its.jnj.com | lld:pubmed |
| pubmed-article:19756557 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19756557 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19756557 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19756557 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19756557 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
